Q1 Earnings Estimate for NHI Issued By Wedbush

National Health Investors, Inc. (NYSE:NHI) – Research analysts at Wedbush issued their Q1 2026 earnings per share estimates for shares of National Health Investors in a report released on Monday, March 17th. Wedbush analyst R. Anderson anticipates that the real estate investment trust will post earnings of $1.20 per share for the quarter. Wedbush currently has a “Outperform” rating and a $88.00 target price on the stock. The consensus estimate for National Health Investors’ current full-year earnings is $4.41 per share. Wedbush also issued estimates for National Health Investors’ Q2 2026 earnings at $1.21 EPS, Q3 2026 earnings at $1.22 EPS and Q4 2026 earnings at $1.23 EPS.

National Health Investors (NYSE:NHI) last announced its earnings results on Tuesday, February 25th. The real estate investment trust reported $1.13 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.03. The company had revenue of $85.75 million for the quarter, compared to analyst estimates of $81.13 million. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%.

Separately, Truist Financial lowered their target price on shares of National Health Investors from $78.00 to $72.00 and set a “hold” rating for the company in a research note on Monday, December 23rd. Three research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, National Health Investors presently has a consensus rating of “Hold” and an average price target of $84.50.

National Health Investors Stock Up 0.4 %

National Health Investors stock opened at $75.41 on Tuesday. National Health Investors has a twelve month low of $57.80 and a twelve month high of $86.13. The stock’s fifty day simple moving average is $69.74 and its 200-day simple moving average is $74.71. The company has a current ratio of 10.29, a quick ratio of 10.29 and a debt-to-equity ratio of 0.92. The firm has a market capitalization of $3.45 billion, a P/E ratio of 25.91, a P/E/G ratio of 4.42 and a beta of 1.08.

National Health Investors Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, May 2nd. Shareholders of record on Monday, March 31st will be issued a $0.90 dividend. The ex-dividend date is Monday, March 31st. This represents a $3.60 dividend on an annualized basis and a yield of 4.77%. National Health Investors’s dividend payout ratio (DPR) is presently 115.38%.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in NHI. Quarry LP purchased a new position in National Health Investors in the third quarter valued at about $27,000. Point72 DIFC Ltd acquired a new stake in shares of National Health Investors in the third quarter valued at approximately $35,000. Loomis Sayles & Co. L P acquired a new stake in shares of National Health Investors in the third quarter valued at approximately $38,000. Assetmark Inc. grew its position in shares of National Health Investors by 27.8% in the third quarter. Assetmark Inc. now owns 648 shares of the real estate investment trust’s stock valued at $54,000 after purchasing an additional 141 shares during the last quarter. Finally, GF Fund Management CO. LTD. acquired a new stake in shares of National Health Investors in the fourth quarter valued at approximately $58,000. 62.51% of the stock is owned by hedge funds and other institutional investors.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.